BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11015203)

  • 21. A phylogenetic analysis reveals an unusual sequence conservation within introns involved in RNA editing.
    Aruscavage PJ; Bass BL
    RNA; 2000 Feb; 6(2):257-69. PubMed ID: 10688364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of an RNA editing substrate bearing 2'-deoxy-2'-mercaptoadenosine.
    Jayalath P; Pokharel S; VĂ©liz E; Beal PA
    Nucleosides Nucleotides Nucleic Acids; 2009 Feb; 28(2):78-88. PubMed ID: 19219738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How do ADARs bind RNA? New protein-RNA structures illuminate substrate recognition by the RNA editing ADARs.
    Thomas JM; Beal PA
    Bioessays; 2017 Apr; 39(4):. PubMed ID: 28217931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Editing of the GLuR-B ion channel RNA in vitro by recombinant double-stranded RNA adenosine deaminase.
    Dabiri GA; Lai F; Drakas RA; Nishikura K
    EMBO J; 1996 Jan; 15(1):34-45. PubMed ID: 8598204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered editing in RNA editing adenosine deaminase ADAR2 gene transcripts of systemic lupus erythematosus T lymphocytes.
    Laxminarayana D; O'Rourke KS; Maas S; Olorenshaw I
    Immunology; 2007 Jul; 121(3):359-69. PubMed ID: 17376196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA-Seq analysis identifies a novel set of editing substrates for human ADAR2 present in Saccharomyces cerevisiae.
    Eifler T; Pokharel S; Beal PA
    Biochemistry; 2013 Nov; 52(45):7857-69. PubMed ID: 24124932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mammalian RNA editing enzyme.
    Melcher T; Maas S; Herb A; Sprengel R; Seeburg PH; Higuchi M
    Nature; 1996 Feb; 379(6564):460-4. PubMed ID: 8559253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral.
    Samuel CE
    Virology; 2011 Mar; 411(2):180-93. PubMed ID: 21211811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The C-terminal domain of RNA Pol II helps ensure that editing precedes splicing of the GluR-B transcript.
    Ryman K; Fong N; Bratt E; Bentley DL; Ohman M
    RNA; 2007 Jul; 13(7):1071-8. PubMed ID: 17525170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural requirements for RNA editing in glutamate receptor pre-mRNAs by recombinant double-stranded RNA adenosine deaminase.
    Maas S; Melcher T; Herb A; Seeburg PH; Keller W; Krause S; Higuchi M; O'Connell MA
    J Biol Chem; 1996 May; 271(21):12221-6. PubMed ID: 8647818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deamination of mammalian glutamate receptor RNA by Xenopus dsRNA adenosine deaminase: similarities to in vivo RNA editing.
    Hurst SR; Hough RF; Aruscavage PJ; Bass BL
    RNA; 1995 Dec; 1(10):1051-60. PubMed ID: 8595560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ADAR2-dependent RNA editing of AMPA receptor subunit GluR2 determines vulnerability of neurons in forebrain ischemia.
    Peng PL; Zhong X; Tu W; Soundarapandian MM; Molner P; Zhu D; Lau L; Liu S; Liu F; Lu Y
    Neuron; 2006 Mar; 49(5):719-33. PubMed ID: 16504947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure and specific RNA binding of ADAR2 double-stranded RNA binding motifs.
    Stefl R; Xu M; Skrisovska L; Emeson RB; Allain FH
    Structure; 2006 Feb; 14(2):345-55. PubMed ID: 16472753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2.
    Higuchi M; Maas S; Single FN; Hartner J; Rozov A; Burnashev N; Feldmeyer D; Sprengel R; Seeburg PH
    Nature; 2000 Jul; 406(6791):78-81. PubMed ID: 10894545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of RNA editing by functional nucleolar sequestration of ADAR2.
    Sansam CL; Wells KS; Emeson RB
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14018-23. PubMed ID: 14612560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine Deaminases That Act on RNA (ADARs).
    Wang Y; Zheng Y; Beal PA
    Enzymes; 2017; 41():215-268. PubMed ID: 28601223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleoside analog studies indicate mechanistic differences between RNA-editing adenosine deaminases.
    Mizrahi RA; Phelps KJ; Ching AY; Beal PA
    Nucleic Acids Res; 2012 Oct; 40(19):9825-35. PubMed ID: 22885375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new strategy to increase RNA editing at the Q/R site of GluA2 AMPA receptor subunits by targeting alternative splicing patterns of ADAR2.
    Chaytow H; Sethw Hassan I; Akbar S; Popplewell L; Dickson G; Chen PE
    J Neurosci Methods; 2021 Dec; 364():109357. PubMed ID: 34536489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. dADAR, a Drosophila double-stranded RNA-specific adenosine deaminase is highly developmentally regulated and is itself a target for RNA editing.
    Palladino MJ; Keegan LP; O'Connell MA; Reenan RA
    RNA; 2000 Jul; 6(7):1004-18. PubMed ID: 10917596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A role of ADAR2 and RNA editing of glutamate receptors in mood disorders and schizophrenia.
    Kubota-Sakashita M; Iwamoto K; Bundo M; Kato T
    Mol Brain; 2014 Jan; 7():5. PubMed ID: 24443933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.